2021
DOI: 10.1016/j.msec.2020.111445
|View full text |Cite
|
Sign up to set email alerts
|

Cross-linked thermosensitive nanohydrogels for ocular drug delivery with a prolonged residence time and enhanced bioavailability

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 12 publications
(4 citation statements)
references
References 34 publications
0
4
0
Order By: Relevance
“…Wen Y. et al [ 67 ] extended the residence time of dexamethasone in the cornea by incorporating it into a nano-hydrogel based on kolliphor P188, kolliphor P407, and polycarbophil. The nano-hydrogel was obtained by the cold solution method at 4 °C.…”
Section: Gels In Ophthalmologymentioning
confidence: 99%
“…Wen Y. et al [ 67 ] extended the residence time of dexamethasone in the cornea by incorporating it into a nano-hydrogel based on kolliphor P188, kolliphor P407, and polycarbophil. The nano-hydrogel was obtained by the cold solution method at 4 °C.…”
Section: Gels In Ophthalmologymentioning
confidence: 99%
“…Due to the small size of nanomedicines, drug molecules are apt to pass through the layers of barriers of the eye, and the permeability is increased, which improves the transfer efficiency of drugs to the postocular section [41]. At the same time, some materials of nanomedicines have adhesion properties, which will prolong the residence time in the targeted site [42], so the retention rate is high, and frequent administration is not required, which can significantly improve patient compliance. Nanomedicines also exhibit some special physical and chemical properties, such as the high surface area to volume ratio, polyvalent structure, high affinity, and target signal amplification ability [43].…”
Section: Nanocarrier-mediated Treatment Of Posterior Eye Diseasesmentioning
confidence: 99%
“…Many studies also deal with the combination of poloxamer 407 and poloxamer 188. Researchers have formulated an in-situ gel with the two types of poloxamer and carbomethylcellulose [ 102 ], while other researchers prepared a nanohydrogel using the two polymers in combination with soy lecithin E200, lecithin oil, glycerol, and polycarbophil [ 103 ], while yet another group used poloxamers 407 and 188 and chitosan gel [ 104 ]. All three studies showed sustained release of the drug.…”
Section: Excipients Used In Ocular Formulations For Modified Drug Deliverymentioning
confidence: 99%